Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory
All Press Releases for March 18, 2010 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Center for Laser Surgery Introduces Restylane-L and Perlane-L
The Center for Laser Surgery announces the availability of Restylane and Perlane with Lidocaine. 
x-small text small text medium text large text


    WASHINGTON, DC, March 18, 2010 /24-7PressRelease/ -- The Center for Laser Surgery announces the immediate availability of Restylane-L and Perlane-L, also known as Restylane with Lidocaine and Perlane with Lidocaine.

These newly FDA approved products are a prepackaged response to the popular practice of mixing the anesthetic lidocaine with Restylane and Perlane for the reduction of pain during injection of these hyaluronic acid dermal fillers. Restylane and Perlane are commonly combined with Dysport or Botox treatment, achieving incredible non-surgical facelift results, also known as the 'liquid lift', reducing common signs of aging such as facial wrinkles, expression lines, skin laxity, and volume loss. The Center for Laser Surgery is the largest Restylane, Perlane and Dysport / Botox practice in the Washington, DC and Mid-Atlantic regions.

Restylane and Perlane are hyaluronic acid dermal fillers. Hyaluronic acid is a natural product found throughout the body, including the skin and eyes. In the skin, hyaluronic acid provides fullness and elasticity. Over time hyaluronic acid and related collagen levels decrease, leading to a loss of elasticity and allowing the formation of wrinkles and folds.

Hyaluronic acid is a hydrophilic molecule, meaning 'water loving'. This allows hyaluronic acid to attract water molecules throughout its breakdown process, which is the reason for the long-lasting volumizing effects of Restylane and Perlane even as the original hyaluronic acid molecules degrade. In general, the effects of hyaluronic acid fillers last between 4-8 months post injection, although results can vary greatly depending on individual physiology. The most common use of Restylane and Perlane are for nasolabial folds, or the lines from the nose to the corners of the mouth.

Restylane and Perlane have an excellent safety profile and are extremely well tolerated. Restylane-L and Perlane-L have the same indications as Restylane and Perlane; however, they are not appropriate for use in patients allergic to lidocaine.

About the Center for Laser Surgery
The Center for Laser Surgery was founded by Dr. Robert M. Adrian, world-renowned laser surgeon and dermatologist. It has become one of the largest full-service cosmetic and laser surgery centers in the DC, Maryland and Virginia area. The Center for Laser Surgery offers cosmetic laser surgery procedures and facial rejuvenations treatments, including wrinkle filler treatments such as Restylane, Perlane and Juvederm. Visit http://www.lasersurgery.com for more information.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Press Release Keywords:
Other Press Release Headlines:

Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Tim Adams
The Center for Laser Surgery

PR Contact
3301 New Mexico Avenue NW
Washington, DC
USA 20016
Voice: (202) 966-8814
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.